Ideas
Liquidity-driven KOSPI large-cap buy.
The Korean market is in a liquidity-driven uptrend, with abundant individual and ETF money absorbing heavy foreign and institutional selling. Foreign investors may return once sentiment stabilizes, even at higher prices, so investors with high cash should buy KOSPI large caps on declines using split purchases.
Avoid software/AMD/Oracle on AI disruption.
Open-source agentic AI such as Anthropic Claude and OpenClaw threatens incumbent software ecosystems. If software companies and their funding channels weaken, AI hardware funding dependent on OpenAI, Oracle, and AMD could be at risk. AMD and Oracle are weak links dependent on OpenAI, while self-funding Google is safer.
Buy Samsung/SK hynix first tranche.
Samsung Electronics and SK hynix are undervalued relative to expected operating profit, and their earnings base is more solid than batteries. If semiconductors and batteries fall together, choose semiconductors; on down days, buy at the close, and if no position exists, a first tranche at current prices is reasonable.
Index ETFs suit wider volatility.
Korean index volatility has expanded because of abundant liquidity without a clear focal point. Index ETFs are easier to trade than individual stocks and can be used to express this volatile market, so investors should pay attention to them.
Value rotation favors Shinhan/KB.
The US and European value-versus-growth allocation gap is extreme and should narrow. If US growth leadership slows, banks can lead, and Korean bank holdings such as Shinhan Financial and KB Financial can follow that rotation.
China consumption boosts travel/casino.
China's Lunar New Year, Korea-China-Japan relations, and consumption recovery drove casino, hotel, travel, and retail names. Money rotates into these areas when semiconductors pause.
L&C Bio favored over Pharma Research.
Pharma Research dropped over 20% despite record earnings as analysts cut targets and growth concerns rose. L&C Bio's product is less painful and more effective, potentially shifting the competitive position. Pharma may see an oversold bounce, but the trend favors L&C Bio.
L&C Bio favored over Pharma Research.
Pharma Research dropped over 20% despite record earnings as analysts cut targets and growth concerns rose. L&C Bio's product is less painful and more effective, potentially shifting the competitive position. Pharma may see an oversold bounce, but the trend favors L&C Bio.
Nuclear names mixed after rally.
Nuclear names have rallied. Hyundai E&C and KEPCO E&C are relatively strong and defensive with target price re-ratings, while Doosan Enerbility corrected as it approached target. There was no new negative catalyst, but the group is mixed near term.
Hyundai long-term buy under 500k.
Foreigners keep selling Hyundai Motor on short-term overextension and tariff concerns, but the stock is not an IT issue and under KRW 500k does not reflect much. Long-term investors can see opportunity, and he may add on further weakness if foreign selling continues.
Solar rebound on China/Musk.
SpaceX's space data-center plan and China's removal of solar export tax rebates create momentum. The US still relies heavily on Chinese solar, and Musk's demand cannot be met by China alone, so Korean solar firms can benefit. Space solar uses gallium arsenide, 90% Chinese, and US-China conflict can favor Korean materials; polysilicon and perovskite are also in focus.
Nuclear decommissioning favors Doosan/Woojin.
The nuclear decommissioning market is large because many aging plants must be dismantled, and Korea is globally competitive in nuclear. Doosan Enerbility and Woojin are exposed to this decommissioning and nuclear equipment opportunity.
Nexen cheap but chase awkward.
Nexen Tire has been very cheap at 0.3-0.4x PBR and remains below 0.5x with around 7% ROE and a target price gap, but after the recent jump chasing it is awkward.
Chemicals/steel improve on China stimulus.
Lotte Chemical's earnings are a burden, but some chemical names such as Daehan Yuhwa and the broader chemicals and steel sectors could improve this year because of restructuring and China stimulus.
Chemicals/steel improve on China stimulus.
Lotte Chemical's earnings are a burden, but some chemical names such as Daehan Yuhwa and the broader chemicals and steel sectors could improve this year because of restructuring and China stimulus.
Korean Air preferred airline play.
China-route revenue exposure for airlines is not as high as assumed. If playing airlines, flagship Korean Air is better than low-cost carriers, and funds will enter as the cycle improves.
KakaoBank stablecoin optionality.
KakaoBank is diversifying through payment and capital acquisitions and stablecoin momentum. If M&A is confirmed and analyst targets rise, it can re-rate, but current targets limit upside and he would not chase now. LG CNS is also a stablecoin-linked name with event-driven volatility before the holiday.
Alphabet capex to lift AI suppliers.
Alphabet's cloud growth accelerated to 48% with 30% margins, and its capex guide of $180B versus $120B expected implies massive AI infrastructure spending. If Alphabet starts to react, Micron, Nvidia, Broadcom, and SanDisk can rally more, but Alphabet has not yet reacted, so this remains a catalyst to watch.
Ukraine rebuild favors construction machinery.
Defense and Ukraine reconstruction stocks are inversely moving, while construction equipment has lagged. If US and European firms lead Ukraine reconstruction, Chinese construction firms are unlikely to participate, benefiting Korean suppliers to Caterpillar and other US/European equipment makers. Some Korean firms have over 50% sales exposure to Caterpillar, and HD Construction Machinery held up.
Avoid KOSDAQ biotech; prefer KOSPI.
Pharma and biotech merits are fading. Well-known retail-held names are weak, and April/May academic conferences are key catalysts; if clinical updates do not lift prices, the sector should be deprioritized. KOSDAQ has overheated via leveraged ETF inflows, so KOSPI is safer.
Avoid KOSDAQ biotech; prefer KOSPI.
Pharma and biotech merits are fading. Well-known retail-held names are weak, and April/May academic conferences are key catalysts; if clinical updates do not lift prices, the sector should be deprioritized. KOSDAQ has overheated via leveraged ETF inflows, so KOSPI is safer.
This 3PRO TV (삼프로TV) video, published February 05, 2026,
features Lee Jae-kyu, Kim Jang-yeol
discussing ^KS11, IGV, AMD, ORCL, 005930.KS, 000660.KS, 055550.KS, 105560.KS, Korean casino/hotel/travel sector, 290650.KQ, 214450.KQ, 000720.KS, 052690.KS, 034020.KS, 005380.KS, Korean solar sector, 322000.KS, 086390.KQ, 105840.KS, 002350.KS, 006650.KS, Korean chemicals/steel sector, 011170.KS, 003490.KS, 323410.KS, 064400.KS, GOOGL, MU, NVDA, AVGO, SNDK, 267270.KS, 041440.KQ, 036890.KQ, XLV, ^KQ11.
21 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Jae-kyu,
Kim Jang-yeol
· Tickers:
^KS11,
IGV,
AMD,
ORCL,
005930.KS,
000660.KS,
055550.KS,
105560.KS,
Korean casino/hotel/travel sector,
290650.KQ,
214450.KQ,
000720.KS,
052690.KS,
034020.KS,
005380.KS,
Korean solar sector,
322000.KS,
086390.KQ,
105840.KS,
002350.KS,
006650.KS,
Korean chemicals/steel sector,
011170.KS,
003490.KS,
323410.KS,
064400.KS,
GOOGL,
MU,
NVDA,
AVGO,
SNDK,
267270.KS,
041440.KQ,
036890.KQ,
XLV,
^KQ11
